Artificial Intelligence has suddenly gone from the fringes of science to being everywhere. So how did we get here? And where's this all heading? In this new series of Science Friction, we're finding out.
…
continue reading
Контент предоставлен Oleksandr Yagensky. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Oleksandr Yagensky или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Player FM - приложение для подкастов
Работайте офлайн с приложением Player FM !
Работайте офлайн с приложением Player FM !
Ep#030: Using iPSCs to Discover New Therapies for Neurodegenerative Disorders with Professor Evangelos Kiskinis
MP3•Главная эпизода
Manage episode 301257884 series 2800366
Контент предоставлен Oleksandr Yagensky. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Oleksandr Yagensky или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
On this episode we take a look at the role induced Pluripotent Stem Cells (iPSCs) are playing in drug discovery and development for neurodegenerative diseases. Our host Oleksandr sat down with Professor Evangelos Kiskinis, who is leading his own research group at the Northwestern University in Chicago. Evangelos and his team are leading the way on the development of novel cell-based models for ALS, epilepsy and other types of neurological conditions.
Check out this episode to learn more about:
◦ Evangelos’s career story and what got him excited in stem cell research
◦ Challenges in modeling neurodegenerative diseases in a dish
◦ iPSC based models for inherited vs sporadic diseases
◦ Transitioning promising in vitro discoveries into clinical trials
◦ iPSC based cell replacement therapies for Parkinsons and Alzheimers disease
◦ The future of iPSC based models in drug discovery
◦ Evangelos’s advice to young scientists pursuing academic career
◦ Get in touch with Evangelos:
◦ LinkedIn: Evangelos Kiskinis
◦ Web: http://evangeloskiskinislab.org/index.html
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
…
continue reading
Check out this episode to learn more about:
◦ Evangelos’s career story and what got him excited in stem cell research
◦ Challenges in modeling neurodegenerative diseases in a dish
◦ iPSC based models for inherited vs sporadic diseases
◦ Transitioning promising in vitro discoveries into clinical trials
◦ iPSC based cell replacement therapies for Parkinsons and Alzheimers disease
◦ The future of iPSC based models in drug discovery
◦ Evangelos’s advice to young scientists pursuing academic career
◦ Get in touch with Evangelos:
◦ LinkedIn: Evangelos Kiskinis
◦ Web: http://evangeloskiskinislab.org/index.html
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
48 эпизодов
MP3•Главная эпизода
Manage episode 301257884 series 2800366
Контент предоставлен Oleksandr Yagensky. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Oleksandr Yagensky или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
On this episode we take a look at the role induced Pluripotent Stem Cells (iPSCs) are playing in drug discovery and development for neurodegenerative diseases. Our host Oleksandr sat down with Professor Evangelos Kiskinis, who is leading his own research group at the Northwestern University in Chicago. Evangelos and his team are leading the way on the development of novel cell-based models for ALS, epilepsy and other types of neurological conditions.
Check out this episode to learn more about:
◦ Evangelos’s career story and what got him excited in stem cell research
◦ Challenges in modeling neurodegenerative diseases in a dish
◦ iPSC based models for inherited vs sporadic diseases
◦ Transitioning promising in vitro discoveries into clinical trials
◦ iPSC based cell replacement therapies for Parkinsons and Alzheimers disease
◦ The future of iPSC based models in drug discovery
◦ Evangelos’s advice to young scientists pursuing academic career
◦ Get in touch with Evangelos:
◦ LinkedIn: Evangelos Kiskinis
◦ Web: http://evangeloskiskinislab.org/index.html
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
…
continue reading
Check out this episode to learn more about:
◦ Evangelos’s career story and what got him excited in stem cell research
◦ Challenges in modeling neurodegenerative diseases in a dish
◦ iPSC based models for inherited vs sporadic diseases
◦ Transitioning promising in vitro discoveries into clinical trials
◦ iPSC based cell replacement therapies for Parkinsons and Alzheimers disease
◦ The future of iPSC based models in drug discovery
◦ Evangelos’s advice to young scientists pursuing academic career
◦ Get in touch with Evangelos:
◦ LinkedIn: Evangelos Kiskinis
◦ Web: http://evangeloskiskinislab.org/index.html
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
48 эпизодов
Все серии
×Добро пожаловать в Player FM!
Player FM сканирует Интернет в поисках высококачественных подкастов, чтобы вы могли наслаждаться ими прямо сейчас. Это лучшее приложение для подкастов, которое работает на Android, iPhone и веб-странице. Зарегистрируйтесь, чтобы синхронизировать подписки на разных устройствах.